TULSA PRO "Preservation of Continence" paper --May 11, 2026

"Prostate Cancer Treatment in the Extreme Apex: Preservation of Continence With Robotic-Assisted MRI-Guided Transurethral Ultrasound Ablation

Victoria Bird • Kathy Busch • Roland Rose • Juan Varela • Joseph Busch

"Abstract
Purpose
MRI-guided transurethral ultrasound ablation (TULSA) is a novel, minimally invasive therapy for prostate cancer designed to preserve urinary continence and erectile function. The original TULSA pivotal trial mandated preservation of 3 mm of apical tissue to protect the external sphincter. We evaluated oncologic and functional outcomes in patients with prostate cancer located at the extreme apex, including lesions abutting or involving the sphincter...."

Love the "The findings should also be interpreted in the context of a relatively short follow-up period. The absence of systematic post-treatment biopsy limits definitive assessment of oncologic control."

Like. No kidding, eh?

👉 https://www.cureus.com/articles/486095-prostate-cancer-treatment-in-the-extreme-apex-preservation-of-continence-with-robotic-assisted-mri-guided-transurethral-ultrasound-ablation!